{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T20:12:13Z","timestamp":1765743133570,"version":"3.48.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,14]]},"DOI":"10.7759\/cureus.99204","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T20:07:32Z","timestamp":1765742852000},"source":"Crossref","is-referenced-by-count":0,"title":["Critical Limb Ischaemia in a Patient With Subcutaneous Nodules: Clues to a Hidden Systemic Disease"],"prefix":"10.7759","author":[{"given":"Vasanth","family":"Kannan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lopez-Lazaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sampreety","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tharun Adithya","family":"Natesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius","family":"Fernandez James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.211393","article-title":"Management of calcinosis cutis in rheumatic diseases","volume":"49","author":"Elahmar H","year":"2022","unstructured":"Elahmar H, Feldman BM, Johnson SR. Management of calcinosis cutis in rheumatic diseases. J Rheumatol. 2022, 49:980-9. 10.3899\/jrheum.211393","journal-title":"J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjae068","article-title":"A case report and review of calcinosis cutis","volume":"9","author":"Bender T","year":"2024","unstructured":"Bender T, Burt M. A case report and review of calcinosis cutis. J Surg Case Rep. 2024, 9:8. 10.1093\/jscr\/rjae068","journal-title":"J Surg Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2015.09.001","article-title":"Calcinosis cutis and calciphylaxis","volume":"106","author":"Jim\u00e9nez-Gallo D","year":"2015","unstructured":"Jim\u00e9nez-Gallo D, Ossorio-Garc\u00eda L, Linares-Barrios M. Calcinosis cutis and calciphylaxis. Actas Dermosifiliogr. 2015, 106:785-94. 10.1016\/j.ad.2015.09.001","journal-title":"Actas Dermosifiliogr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar SU","year":"2015","unstructured":"Nigwekar SU, Kroshinsky D, Nazarian RM, et al.. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015, 66:133-46. 10.1053\/j.ajkd.2015.01.034","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-022-08922-4","article-title":"Autoantibody markers of increased risk of malignancy in patients with dermatomyositis","volume":"63","author":"Marz\u0119cka M","year":"2022","unstructured":"Marz\u0119cka M, Niemczyk A, Rudnicka L. Autoantibody markers of increased risk of malignancy in patients with dermatomyositis. Clin Rev Allergy Immunol. 2022, 63:289-96. 10.1007\/s12016-022-08922-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.01.016","article-title":"Calcinosis in rheumatic diseases","volume":"34","author":"Boulman N","year":"2005","unstructured":"Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005, 34:805-12. 10.1016\/j.semarthrit.2005.01.016","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2013.39439","article-title":"Eruptive xanthomas","volume":"30","author":"Zaremba J","year":"2013","unstructured":"Zaremba J, Zaczkiewicz A, Placek W. Eruptive xanthomas. Postepy Dermatol Alergol. 2013, 30:399-402. 10.5114\/pdia.2013.39439","journal-title":"Postepy Dermatol Alergol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa122","article-title":"Management of familial hypercholesterolemia: current status and future perspectives","volume":"5","author":"Lui DT","year":"2021","unstructured":"Lui DT, Lee AC, Tan KC. Management of familial hypercholesterolemia: current status and future perspectives. J Endocr Soc. 2021, 5:10. 10.1210\/jendso\/bvaa122","journal-title":"J Endocr Soc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173525","article-title":"Gout and diet: a comprehensive review of mechanisms and management","volume":"14","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Chen S, Yuan M, Xu Y, Xu H. Gout and diet: a comprehensive review of mechanisms and management. Nutrients. 2022, 14:5. 10.3390\/nu14173525","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/japtr.japtr_144_23","article-title":"The inflammation process of gout arthritis and its treatment","volume":"14","author":"Parisa N","year":"2023","unstructured":"Parisa N, Kamaluddin MT, Saleh MI, Sinaga E. The inflammation process of gout arthritis and its treatment. J Adv Pharm Technol Res. 2023, 14:166-70. 10.4103\/japtr.japtr_144_23","journal-title":"J Adv Pharm Technol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.66593","article-title":"Tophi as first manifestation of gout","volume":"76","author":"Koley S","year":"2010","unstructured":"Koley S, Salodkar A, Choudhary S, Bhake A, Singhania K, Choudhury M. Tophi as first manifestation of gout. Indian J Dermatol Venereol Leprol. 2010, 76:393-6. 10.4103\/0378-6323.66593","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23188","article-title":"Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients","volume":"69","author":"Albayda J","year":"2017","unstructured":"Albayda J, Pinal-Fernandez I, Huang W, et al.. Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients. Arthritis Care Res (Hoboken). 2017, 69:1771-6. 10.1002\/acr.23188","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan A","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018, 17:816-28. 10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000001036","article-title":"Calcinosis in dermatomyositis","volume":"36","author":"Davuluri S","year":"2024","unstructured":"Davuluri S, Chung L, Lood C. Calcinosis in dermatomyositis. Curr Opin Rheumatol. 2024, 36:453-8. 10.1097\/BOR.0000000000001036","journal-title":"Curr Opin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg IE","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al.. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017, 76:1955-64. 10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12954","article-title":"MRI and muscle imaging for idiopathic inflammatory myopathies","volume":"31","author":"Malartre S","year":"2021","unstructured":"Malartre S, Bachasson D, Mercy G, Sarkis E, Anquetil C, Benveniste O, Allenbach Y. MRI and muscle imaging for idiopathic inflammatory myopathies. Brain Pathol. 2021, 31:e12954. 10.1111\/bpa.12954","journal-title":"Brain Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte MS","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, et al.. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019, 69:3S-125S. 10.1016\/j.jvs.2019.02.016","journal-title":"J Vasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437598-critical-limb-ischaemia-in-a-patient-with-subcutaneous-nodules-clues-to-a-hidden-systemic-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T20:07:33Z","timestamp":1765742853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437598-critical-limb-ischaemia-in-a-patient-with-subcutaneous-nodules-clues-to-a-hidden-systemic-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.99204","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,14]]}}}